CAS: 1229582-33-5
Ref: 7W-GW3144
| 1mg | 265.00 € | ||
| 5mg | 454.00 € | ||
| 10mg | 690.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
![3-(1H-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridine](https://static.cymitquimica.com/products/54/thumb/BISN0232.jpg)
3-(1H-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridine
CAS:1229582-33-5
Molecular weight:
421.54g/mol
Ref: 54-BISN0232
| 1g | 1,757.00 € | ||
| 50mg | 202.00 € | ||
| 100mg | 329.00 € | ||
| 250mg | 540.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-K-031084
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
URMC-099
CAS:1229582-33-5
URMC-099: oral, brain-accessible MLK/LRRK2 inhibitor; IC50 - MLK1/2/3/DLK: 19/42/14/150 nM, LRRK2: 11 nM.
Formula:
C27H27N5
Purity:
98.43% - 99.32%
Color and Shape:
Solid
Molecular weight:
421.54
- Inhibitors
- ROCK
- Stem Cell and Derivatives
- Stem Cells
- See more categories
- Autophagy
Ref: TM-T6057
| 5mg | 56.00 € | ||
| 10mg | 85.00 € | ||
| 25mg | 138.00 € | ||
| 50mg | 217.00 € | ||
| 100mg | 371.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 3D-FU170951
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
URMC-099
CAS:1229582-33-5
Applications URMC-099 is an orally bioavailable MLK3 inhibitor used in the treatment of Parkinson’s disease …
Formula:
C27H27N5
Color and Shape:
Pale Beige to Pale Brown Solid
Molecular weight:
421.54
Ref: TR-U842000
| 25mg | Discontinued | Request information |
